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Abstract
Objective: To improve counseling on congenital lung malformations (CLM) by describing
long‐term outcomes of children either operated on or managed by observation.
Study design: We analyzed lung function (spirometry), exercise tolerance (Bruce
treadmill), and physical growth of 8‐year‐old children with CLM who participated in
our longitudinal prospective follow‐up program. The data are shown as median
standard deviation scores (SDS) with IQR, or estimated marginal means (95% CI) on
the basis of general linear models.
Results: Twenty‐nine (48%) of the 61 children had required surgery at a median age
of 108 (IQR: 8‐828) days, and 32 (52%) were managed by observation. In the surgery
group, all lung function measurements (except for forced vital capacity [FVC]) were
significantly below 0 SDS, with median FEV1 −1.07 (IQR: −1.70 to −0.56), FEV1/FVC
−1.49 (−2.62 to −0.33), and FEF25%‐75% −1.95 (−2.57 to −0.63) (all P < 0.001). Children
in the observation group had normal FEV1 and FVC, whereas FEV1/FVC (−0.81 (−1.65
to −0.14)) and FEF25%‐75% (−1.14 (−1.71 to −0.22)) were significantly below 0 SDS
(both P < 0.001). Mean exercise tolerance was significantly below 0 SDS in both
groups (observation: −0.85 (95% CI: −1.30 to −0.41); surgery: −1.25 (−1.69 to −0.80));
eight (28%) children in the observation group and ten (40%) in the surgery group
scored <−1 SDS. Physical growth was normal in both groups.
Conclusion: Children with CLM may be at risk for reduced lung function and exercise
tolerance, especially those who required surgery. As little pulmonary morbidity was
found in children with asymptomatic CLM, this study supports a watchful waiting
approach in this group.
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1 | INTRODUCTION
Congenital lung malformations (CLM) are a heterogeneous group of
malformations, including cystic pulmonary airway malformation (CPAM),
bronchopulmonary sequestration, congenital lobar emphysema,
bronchogenic cysts, and hybrid forms of these lesions.1 CLM are
increasingly detected prenatally as a result of routine fetal anomaly
scanning and improved ultrasound technology. The current estimated
incidence is 4.15 per 10 000 births.2 Children with CLM who develop
symptoms, either directly after birth or later in life, undergo surgery.
However, the majority of children with CLM remain asymptomatic. The
best management strategy—ie elective surgical resection or watchful
waiting—in these children remains controversial, because of uncertainty
about the risk of postoperative complications, the most accurate timing
of surgical resection, and the risks of infection and malignancy related
with watchful waiting.3,4 A previous study at our center showed airflow
obstruction in approximately one‐third of children with CLM at the ages
of 6 and 12 months, both in those who had required surgery and in
those who remained asymptomatic.5 The data on the long‐term
outcome are scarce, especially in children with asymptomatic CLM.6–8
To optimize follow‐up and to improve counseling, we primarily
aimed to describe pulmonary outcomes (ie lung function, exercise
tolerance and lower respiratory tract infections [LRTIs]) and physical
growth in 8‐year‐old children with CLM; both in those operated on
and those managed by observation. We hypothesized that children
with asymptomatic CLM have normal growth and no pulmonary
morbidity and that children who needed surgery have a more
complicated clinical course with growth failure and pulmonary
morbidity. Secondarily, physical growth, exercise tolerance, and
LRTIs were evaluated longitudinally in all children.
2 | MATERIALS AND METHODS
2.1 | Study population
We analyzed prospectively collected data of live‐born children born with
CLM between January 1999 and March 2010, and followed in the
Erasmus Medical Center‐Sophia Children's Hospital Rotterdam. These
children had been diagnosed either prenatally or after birth, because of
symptoms or coincidentally. The postnatal diagnosis had been made using
computed tomography (CT) and/or histology. In our hospital, we advocate
a wait‐and‐see policy in children with asymptomatic CLM; this group is
scheduled for CT‐imaging approximately 6 months after birth. Those who
develop symptoms—such as respiratory distress after birth or recurrent
LRTIs—undergo surgical resection, usually after a CT‐scan is made.
Parents of all surviving children with CLM are invited to enter their child
in our longitudinal prospective follow‐up program. Since 1999, this
program is the standard of care for children with anatomical congenital
malformations treated in our center.9 Follow‐up visits are planned at the
ages of 1, 2, 5 and 8 years. The Medical Ethical Review Board waived
approval because data obtained during routine care were retrospectively
analyzed (MEC‐2018‐1086).
2.2 | Variables and definitions
Neonates born <37 weeks' gestation were considered preterm.
Those with a birth weight below the 10th centile of Dutch reference
curves were considered small for gestational age.10 Multiple
congenital anomalies (MCA) were only documented if they required
surgery or multiple follow‐up visits. We registered the need for
hospitalization within 28 days after birth, including the length of stay
and the need for and duration of respiratory support (ie supple-
mental oxygen only, mechanical ventilation, or extracorporeal
membrane oxygenation [ECMO]). Children who had required
supplemental oxygen for at least 28 days were diagnosed with
chronic lung disease.11 Spinal and thoracic deformities were assessed
during a physical examination at 8 years of age.
2.3 | Pulmonary outcomes
2.3.1 | Lung function
Dynamic lung volumes were measured using spirometry at the age of
8 years. We documented the forced expiratory volume in 1 second
(FEV1), forced vital capacity (FVC), FEV1/FVC, and the forced
expiratory flow (FEF) at 25%‐75% of FVC (FEF25%‐75%). Standard
deviation scores (SDS) were calculated according to the Global Lung
Initiative 2012, with − 1.64 to + 1.64 SDS considered as normal
range.12 In addition, bronchodilator reversibility was reported.
Significant reversibility was defined as an increase in FEV1 of
>12% compared with the pre‐bronchodilator test. Static lung
volumes were measured by body plethysmography and expressed
in residual volume (RV), total lung capacity (TLC), and RV/TLC.
Diffusion capacity was assessed with carbon monoxide diffusion
(DLCO) and DLCO corrected for alveolar volume (DLCO/VA). SDS
for static lung volumes and diffusion capacity were calculated
according to the Utrecht data set.13
2.3.2 | Exercise tolerance
Exercise tolerance was determined with the Bruce treadmill
protocol.14 Time to the maximal effort was assessed at 5 and 8
years, and converted to SDS according to Dutch reference
values.15,16
2.3.3 | Occurrence of LRTIs
At each follow‐up visit (1, 2, 5, and 8 years), parents reported
whether or not their child had suffered from an LRTI in the past year.
Only LRTIs treated with antibiotics were documented.
2.3.4 | Additional imaging
The program does not include routine imaging at 8 years of age yet.
Children were, however, referred to the pediatric pulmonologist in a
low‐threshold setting.
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2.4 | Physical growth
Height and weight were measured at 1, 2, 5, and 8 years of age. We
calculated height‐for‐age (HFA) and weight‐for‐height (WFH) SDS
according to Dutch reference norms; −2 to +2 SDS was considered
normal range.17,18 Target height SDS was calculated from parental
heights.19 To correct HFA for target height, distance‐to‐target‐height
(DTH) SDS was calculated as follows: DTH SDS =HFA SDS – target
height SDS.
2.5 | Statistical analysis
The data are summarized as number (%) or median (interquartile range
[IQR]), as appropriate. Differences in characteristics between the
observation group and the surgery group were evaluated with chi‐
square or Fisher's exact tests for categorical data, and with Mann‐
Whitney tests for continuous data. We assessed withWilcoxon signed‐
rank tests whether median lung function parameters were below 0
SDS. The courses of exercise tolerance and physical growth over time
were evaluated with general linear models. These models included the
following independent variables: need for surgery (coded as a time‐
dependent dichotomous variable: negative before and positive after
surgery), the time point (5 and 8 years in case of exercise tolerance; 1,
2, 5 and 8 years in case of physical growth), the interaction effect of
the need for surgery and time point, and presence of MCA. To account
for within‐subject correlations, we used an unstructured error
covariance matrix. The results are summarized as estimated marginal
means (ie the predicted values of the dependent variable, adjusted for
covariates in the model) with their 95% confidence intervals (95% CIs).
Statistical analyses were performed using IBM SPSS Statistics 24, with
a two‐sided significance level of 0.05.
3 | RESULTS
Of 79 infants born with CLM between January 1999 and March
2010, 76 (96%) had survived. The three others, who had been
diagnosed prenatally, had died within 2 weeks after birth. Two of
them had a pneumonectomy because of CPAM in the entire lung, and
required ECMO for 5 and 13 days, respectively. Both died because of
therapy‐resistant pulmonary hypertension. The other infant was
diagnosed with bronchopulmonary sequestration and died of cecum
perforation complicated by septic shock and intracerebral hemor-
rhage.
Sixty‐one (80%) children underwent follow‐up examination at 8 years
of age, of whom 43 (70%) had been seen at all four‐time points (Figure 1).
Characteristics of children examined at 8 years and those not examined
did not differ significantly, except for the proportion of children not
subjected to CT or histology, which was higher in those not examined
(E‐Table 1). E‐Figure 1 provides an overview of the number of children
per follow‐up time point, categorized according to the type of manage-
ment (ie observation or surgery).
Twenty‐nine of the 61 (48%) children had undergone surgery at a
median age of 108 (IQR: 8‐828) days. The indications for surgery were
respiratory insufficiency (14/29, 48%), recurrent infections (7/29, 24%),
increasing size (3/29, 7%), and miscellaneous (5/29, 17%).
One child with an extralobar bronchopulmonary sequestration
had undergone embolization of the aberrant artery at 3 years of
age because of cardiac insufficiency. This child was included in the
surgery group. No features of malignancy were found in any of the
resected specimens. The children in the surgery group had less often
been diagnosed prenatally; they had a slightly shorter median
gestational age at birth, and they had more often required
mechanical ventilation than those in the observation group (Table 1).
Surviving children
n=76
In follow-up at 8 years 
n=61
No follow-up at 8 years 
n=15
 - Diagnosed > 8 years: n=1
 - Refusal: n=11
 - Organisational: n=3
Complete follow-up 
(at 1, 2, 5, 8 years) 
n=43
 - Observation:      n=23 
 - Surgery before FU at 1y:    n=17 
 - Surgery between FU 1-2y:  n=1 
 - Surgery between FU 2-5y:  n=2 
Incomplete follow-up* 
n=18
 - Observation:       n=9 
 - Surgery before FU at 1y:     n=2 
 - Surgery between FU 1-2y:   n=3 
 - Surgery between FU 2-5y:   n=2
 - Surgery between FU 5-8y:   n=2 
Children with CLM born
Jan 1999 - Mar 2010
n=79
Deceased
n=3
F IGURE 1 Inclusion flowchart CLM,
congenital lung malformations, FU, follow‐
up, y: years. %"* Reasons for incomplete
follow‐up: organisational (n = 10; seen at 1,
5, and 8 y: n = 1; seen at 2, 5 and 8 y: n = 4;
seen at 5 and 8 y: n = 4; seen at 8 y: n = 1),
refusal (n = 6; seen at 1, 2, and 8 y: n = 3;
seen at 1, 5, and 8 y: n = 3), diagnosed
>1 year (n = 1, seen at 2, 5, and 8 y),
diagnosed >2 y (n = 1, seen at 5 and 8 y).%"
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TABLE 1 Prenatal, perinatal, and postnatal characteristics of children examined at 8 y (n = 61)
Observation group Surgery groupa
n (n = 32; 52%) n (n = 29; 48%) P value
Maternal age, y 31 30.7 (29.0‐35.1) 22 29.6 (26.9‐35.1) 0.43
Male sex 32 16 (50%) 29 20 (69%) 0.13
Multiple pregnancy 32 ‐ 29 2 (7%) 0.22
Prenatal characteristics
Prenatal diagnosis 32 29 (91%) 29 18 (62%) 0.01
Gestational age, wk at diagnosis 29 20.4 (19.9‐21.7) 15 20.9 (20.1‐29.0) 0.15
Perinatal characteristics
Cesarean section 32 8 (25%) 23 2 (9%) 0.17
Gestational age at birth, wk 32 39.6 (28.9‐41.0) 25 38.7 (36.5‐40.1) 0.02
Preterm birth 32 3 (9%) 29 7 (24%) 0.17
Birth weight, gm 32 3503 (2878‐3879) 26 3070 (2838‐3648) 0.13
Small for gestational age 32 3 (9%) 22 1 (5%) 0.64
Apgar score at 5min 32 9 (9‐10) 23 9 (8‐10) 0.64
Apgar score <7 at 5 min 32 2 (6%) 24 2 (8%) 1.00
Umbilical cord pH 29 7.28 (7.26‐7.34) 16 7.30 (7.26‐7.36) 0.64
Postnatal characteristics
Type of CLM 32 29
CPAM 15 (47%) 13 (45%) 0.87
Bronchopulmonary sequestration 5 (16%) 8 (28%) 0.26
Congenital lobar emphysema 4 (13%) 4 (14%) 1.00
Bronchogenic cyst ‐ 2 (7%) 0.22
Hybrid or inconclusiveb 4 (13%) 2 (7%) 0.67
CLM in regression 3 (9%) ‐ 0.24
Insufficient diagnostics (no CT or histology) 1 (3%) ‐ 1.00
CT imaging available 32 31 (97%) 29 25 (86%) 0.18
Age at CT, mo 31 3.0 (0.1‐4.5) 25 1.3 (0.1‐6.3) 0.84
Localization of CLM 32 29
Left upper lobe 5 (16%) 3 (10%) 0.71
Left lower lobe 7 (22%) 8 (28%) 0.61
Right upper lobe 4 (13%) ‐ 0.11
Right middle lobe 1 (3%) 1 (3%) 1.00
Right lower lobe 13 (41%) 8 (28%) 0.28
Multilobar 2 (6%) 4 (14%) 0.41
Mediastinal ‐ 3 (10%) 0.10
Extralobar ‐ 2 (7%) 0.22
Multiple congenital anomaliesc 32 6 (19%) 27 5 (17%) 0.88
Hospitalized ≤28 d after birth 32 32 (100%) 27 24 (89%) 0.09
Duration, d 32 4 (2‐8) 23 14 (3‐29) 0.003
Respiratory support during hospitalization 32 24
None 21 (66%) 7 (29%) 0.01
Supplemental oxygen only 8 (25%) 4 (17%) 0.45
Mechanical ventilation 3 (9%) 10 (42%) 0.01
(Continues)
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Spinal and thoracic deformities were assessed in 56 (92%) children at
8 years of age. None of them had scoliosis. One child in the observation
group had pectus excavatum (1/28; 4%) vs three children in the surgery
group (3/28; 11%). These three children had all undergone thoracotomy.
3.1 | Pulmonary outcomes
3.1.1 | Lung function
Reliable spirometry tests at 8 years of age were obtained in 57/61
(93%) children. Spirometry results per diagnosis are shown in Figure 2.
Overall, children in the observation group (n = 31) had median FEV1
SDS (−0.37 (IQR: −0.94 to 0.49)), and FVC SDS (0.10 (−0.59 to 0.74))
comparable to reference norms, whereas median FEV1/FVC SDS
(−0.81 (− 1.65 to −0.14)) and FEF25%‐75% SDS (−1.14 (−1.71 to −0.22))
were significantly below 0 (both P < 0.001). Four (13%) children scored
FEV1 < −1.64 SDS, two (6%) scored FVC < −1.64 SDS, and FEV1/FVC
and FEF25%‐75% were <−1.64 SDS in eight (26%) children.
In the surgery group (n = 26), median FVC SDS was comparable to
reference norms (−0.39 (IQR: −1.16 to 0.68)). The other lung function
parameters were significantly below 0 SDS, with median FEV1 −1.07
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Diagnosis:
1. CPAM
2. Bronchopulmonary sequestrationSurgery group
Observation group
3. Congenital lobar emphysema
 
4. Bronchogenic cyst
5. Hybrid/inconclusive
6. CLM in regression
7. Insufficient diagnostics
(A) (B)
(C) (D)
F IGURE 2 Scatter plots showing lung functions at 8 years of age in the observation group and in the surgery group, per diagnosis. FEV1,
forced expiratory volume in 1 second; FVC, forced vital capacity; FEF25‐75%: forced expiratory flow at 25%‐75% of FVC; CPAM, congenital
pulmonary airway malformation; CLM, congenital lung malformation
TABLE 1 (Continued)
Observation group Surgery groupa
n (n = 32; 52%) n (n = 29; 48%) P value
ECMO ‐ 3 (13%) 0.07
Chronic lung disease 32 ‐ 27 3 (11%) 0.09
Abbreviations: CLM, congenital lung malformation; CPAM, congenital pulmonary airway malformation; CT, computed tomography; ECMO, extracorporeal
membrane oxygenation; n/a, not applicable.
The data presented as median (interquartile range) or n (%).
aThoracotomy (n = 20); thoracoscopy (n = 6); laparotomy (n = 1); embolization (n = 1); unknown (n = 1).
bCPAM and/or congenital lobar emphysema (n = 3); CPAM and/or bronchogenic cyst (n = 3).
cVentricular septal defect (n = 2); atrial septal defect (n = 2); tetralogy of Fallot (n = 1); patent ductus arteriosus and duplicated renal collecting system
(n = 1); laryngeal cyst (n = 1); Filamin A deficiency (n = 1); congenital diaphragmatic hernia (n = 1); bladder exstrophy and anal atresia and duplicated renal
collecting system (n = 1); bilateral ovarian cysts (n = 1).
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(−1.70 to −0.56), FEV1/FVC −1.49 (−2.62 to −0.33) and FEF25%‐75%
−1.95 (−2.57 to −0.63) (all P < 0.001). Nine (35%) children scored
FEV1 < −1.64 SDS, three (12%) scored FVC < −1.64 SD, FEV1/FVC
was <−1.64 SDS in 12 (46%) children, and 14 (56%) scored
FEF25%‐75% < −1.64 SDS. Compared with children in the observation
group, those in the surgery group had lower median FEV1 SDS
(P = 0.007), and a higher proportion scored FEF25%‐75% < −1.64 SDS
(P = 0.02); the other parameters did not differ significantly.
Bronchodilator reversibility was tested in 38 children. Two of 19
(11%) children in the observation group and 2/19 (11%) in the
surgery group showed significant reversibility. One of these four
children had been prescribed inhaled corticosteroids; the others
were asymptomatic.
Body plethysmography was performed in 41/61 (67%) children.
In the observation group (n = 20), median static lung volumes (SDS)
were comparable to reference norms (RV 0.15 (IQR: −0.33 to 0.40);
TLC 0.13 (−1.12 to 0.58); RV/TLC 0.17 (−0.34 to 0.78)). In the surgery
group (n = 21), median RV (−0.23 (−1.34 to 0.13)), and RV/TLC (−0.20
(−1.21 to 1.01)) were comparable to reference norms, whereas
median TLC was significantly below 0 (−0.44 (−1.35 to 0.19),
P = 0.047). Body plethysmography parameters did not differ sig-
nificantly between both groups.
Diffusion capacity was assessed in 37/61 (61%) children. In both
groups, median DLCO and DLCO/VA SDS were comparable to
reference norms (observation group (n = 20): 0.05 (IQR: −1.03 to
0.54) and 0.07 (−0.50 to 0.54), respectively; surgery group (n = 17):
0.05 (−0.41 to 0.52) and −0.16 (−0.69 to 0.35), respectively).
Diffusion capacity did not differ significantly between the observa-
tion group and the surgery group.
3.1.2 | Exercise tolerance
Exercise tolerance had been assessed in 44/57 (77%) children at
5 years and in 54/61 (89%) at 8 years of age. Forty‐three children
were seen at both time points. At 5 years, the estimated marginal
mean exercise tolerance SDS of children in the observation group
(n = 25; −0.13 (95% CI: −0.56 to 0.30)) did not differ significantly
from 0 SDS. Those in the surgery group (n = 19) scored significantly
below 0 SDS (−0.56 (−1.05 to −0.07)). At 8 years, both groups scored
significantly below 0 SDS (observation group (n = 29): −0.85 (−1.30 to
−0.41); surgery group (n = 25): −1.25 (−1.69 to −0.80)). Eight (28%)
children in the observation group and 10 (40%) in the surgery group
scored <−1 SDS, of whom two children in the observation group and
three in the surgery group scored <−2 SDS.
Overall, the general linear model analysis showed a significant
decrease in exercise tolerance SDS from 5 to 8 years of age of −0.70
(95% CI: −1.01 to −0.40). Children in the surgery group had significantly
lower exercise tolerance SDS than those in the observation group
(mean difference: 0.49 (0.03 to 0.95)).
3.1.3 | Occurrence of LRTIs
LRTIs during the past year had been reported for 2/50 (4%) children
at 1 year follow‐up, in 4/51 (8%) at 2 years, for 7/57 (12%) at 5 years,
and for 3/61 (5%) children at 8 years. Of 61 children in follow‐up,
14 (23%) had suffered at least one LRTI (E‐Figure 2). Three of them
had an LRTI after surgical resection, four underwent surgical
resection because of the infection, and seven had been managed by
observation despite having had an LRTI.
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F IGURE 3 Line charts showing physical growth parameters measured at ages 1, 2, 5, and 8 years. Symbols represent estimated marginal means
with 95% confidence intervals, on the basis of a general linear model that includes age, need for surgery (coded as a time‐dependent dichotomous
variable), the interaction effect of need for surgery and time point, and the presence of multiple congenital anomalies as explanatory variables
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3.1.4 | Additional imaging
In 37 of 61 (61%) children in follow‐up at 8 years, additional imaging
had been performed after the initial diagnostic CT‐scan, at a median
age of 8.4 years (range, 1.2‐15.4 years). Additional imaging had been
performed mostly because of respiratory symptoms (n = 19, 51%),
including coughing, fatigue, or deteriorating lung function, or because
previous imaging had been inconclusive with respect to the type of
CLM (n = 5, 14%). Eighteen of them were managed by watchful
waiting (observation group), 18 had undergone surgery before the
imaging, and one child underwent surgical resection after additional
imaging.
Of the 37 children who underwent imaging, CT‐imaging was
performed in 21 (57%) children, 14 (38%) children were subjected to
X‐ray, and two (5%) children underwent magnetic resonance imaging.
Of the 23 children who had undergone CT or magnetic resonance
imaging, gas trapping was reported in 10 (43%).
3.2 | Physical growth
Physical growth data of all children in follow‐up at 8 years are shown
in Figure 3. Estimated marginal mean HFA, DTH, and WFH SDS were
within reference norms at 1, 2, 5, and 8 years in both the observation
group and the surgery group. Only WFH SDS in the surgery group at
2 years (−0.49 (95% CI: −0.95 to −0.03)) was significantly below 0
SDS.
Overall, the general linear model analysis showed a significant
decrease of HFA SDS (−0.26 (−0.46 to −0.07)) and DTH SDS (−0.26
(−0.46 to −0.06)) between 2 and 5 years, and a significant increase of
WFH SDS (0.41 (0.10 to 0.71)) between 2 and 8 years. Neither the
presence of MCA nor the need for surgery affected any physical
growth parameter.
4 | DISCUSSION
To our knowledge, this is the first study to evaluate lung function,
exercise tolerance, and physical growth in 8‐year‐old children with
either observationally or surgically managed CLM. As we hypothe-
sized, most children with asymptomatic CLM had normal lung
function parameters, exercise tolerance, and physical growth. Those
who had required surgery had worse lung function and exercise
tolerance than healthy children, but, in contrast to what we expected,
showed normal physical growth.
The optimal management strategy in asymptomatic CLM remains
debatable.4 In this study, more than half of the children with CLM did
not require surgical resection, which is consistent with a previous
study that advocated a watchful waiting approach.6 When only
looking at the infants who had been diagnosed prenatally, it appears
that approximately two‐thirds (ie 29/47, 62%) could be managed
observationally. Children in the observation group showed normal
physical growth, and most of them had normal lung function
parameters and exercise tolerance at 8 years of age, which supports
a watchful waiting approach in asymptomatic CLM. About a quarter
of children in this group did show reduced lung function parameters
and/or exercise tolerance, however, and clinicians and parents should
be aware of this. Several factors could have negatively influenced
pulmonary outcomes, such as parental smoking and the presence of
asthma. Parents should be carefully counseled and encouraged to
stimulate physical activity and sport participation of their children.
Approximately half of the children in the surgery group had
abnormal lung function parameters (except for FVC, which was
abnormal in only 12%), and mean exercise tolerance fell below −1 SD
at 8 years of age. In contrast, a previous study showed that over 75%
of 21 children who had undergone lobectomy for CLM had normal
lung function at a median age of 6 years (range 3‐16).20 Most of these
children, however, had been diagnosed prenatally and underwent
surgical resection regardless of having symptoms. In our study, the
majority of these children would have been included in the
observation group. We, therefore, assume that the pulmonary
morbidity we found in our surgery group was caused by the severity
of the CLM, rather than by the surgery itself. In other words, these
malformations may not be just isolated or localized defects, and
weaknesses might occur in adjacent lung sections. In addition, while
we included children who underwent surgery in the first decade of
this century, the 21 children in the previous study underwent surgery
between 2005 and 2016, when medical technologies—including
surgical techniques, ventilation methods, and use of ECMO—had
advanced.
At each follow‐up time point, 4%‐12% of parents reported that
their child had suffered from an LRTI during the past year. This is
higher than the incidence reported in healthy European children (ie
14.5 per 10 000 children per year).21 Two recent studies evaluated
the data of children with CLM who had been diagnosed prenatally; in
both studies, 9% of children required surgery because of respiratory
infections.6,22 In our study, LRTIs in the observation group did not
always lead to surgical resection, for example, because children
recovered well from a single LRTI or because no imaging data were
available to confirm that the LRTI had been located in the same lobe
as the CLM. LRTIs have also been reported in children with CLM in
regression or after surgery. Hence, resection does not necessarily
eliminate LRTIs; previous research even reported a paradoxical
increase of pulmonary infections after resection of CLM,7 and a high
prevalence of recurrent LRTIs (ie 19%) in 7‐year‐olds who had
undergone early surgery regardless of having symptoms.23
Strengths of our study include the data collection from a
longitudinal prospective follow‐up program, the high proportion
(80%) of children that entered this program, the length of follow‐up
of both observationally and surgically managed children, and the
standardized assessments during follow‐up. Several limitations need
to be addressed. First, we included children born from 1999 onwards,
whereas the 20‐week fetal anomaly scan was introduced in the
Netherlands only in 2007. This has probably led to an under-
estimation of the number of children in the observation group.
Second, there was a selection bias of children in the surgery group: as
only symptomatic children underwent surgery, it is no surprise that
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this group showed more morbidity. In some children, symptoms even
led to the diagnosis of CLM. Third, our study does not answer the
question whether early surgery in all children with CLM, including
asymptomatic ones, would have resulted in everyone having a normal
lung function and exercise tolerance or whether it would have
worsened pulmonary outcomes. To find out whether surgical
treatment could be superior to observation management in children
with asymptomatic CLM, a randomized controlled trial or case‐
control study could be carried out to evaluate long‐term outcomes in
asymptomatic children who either do or do not undergo surgery.
Fourth, LRTIs were parent‐reported and we were unable to include
the data on specific pathogens or on the location of the LRTI. To limit
recall bias, we asked parents to report LRTIs that had occurred
during the 12 months preceding the follow‐up visit; hence, we have
no data on LRTIs for ages 2 to 4 years and 5 to 7 years. Last, the
patient samples were too small and the follow‐up period was not long
enough to evaluate the risk of malignancy in CLM, particularly
CPAM.
In conclusion, children with CLM may be at risk for reduced lung
function and exercise tolerance, especially those who required
surgery. This study does not give a clear answer regarding the
optimal management strategy in children with asymptomatic CLM.
Still, as little pulmonary morbidity was found in these children, this
study supports a watchful waiting approach in this group. Continued
follow‐up until adulthood is recommended to evaluate the risk of
malignancy in both symptomatic and asymptomatic CLM.
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